Sun Pharma presents data from first-in-human phase 1 studies of GL0034 EP News Bureau Jun 28, 2023 GL0034 (utreglutide) is an investigational novel glucagon-like peptide 1 receptor agonist (GLP- 1RA) in development as a…
